U.S. Markets closed

Consolidated Research: 2018 Summary Expectations for Novavax, Caesars Entertainment, SeaWorld Entertainment, LendingTree, CVS Health, and TherapeuticsMD — Fundamental Analysis, Key Performance Indications

NEW YORK, Oct. 24, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Novavax, Inc. (NVAX), Caesars Entertainment Corporation (CZR), SeaWorld Entertainment, Inc. (SEAS), LendingTree, Inc. (TREE), CVS Health Corporation (CVS), and TherapeuticsMD, Inc. (TXMD), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

NVAX DOWNLOAD: http://MarketSourceResearch.com/register/?so=NVAX
CZR DOWNLOAD: http://MarketSourceResearch.com/register/?so=CZR
SEAS DOWNLOAD: http://MarketSourceResearch.com/register/?so=SEAS
TREE DOWNLOAD: http://MarketSourceResearch.com/register/?so=TREE
CVS DOWNLOAD: http://MarketSourceResearch.com/register/?so=CVS
TXMD DOWNLOAD: http://MarketSourceResearch.com/register/?so=TXMD

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Novavax, Inc. (NVAX), Caesars Entertainment Corporation (CZR), SeaWorld Entertainment, Inc. (SEAS), LendingTree, Inc. (TREE), CVS Health Corporation (CVS), and TherapeuticsMD, Inc. (TXMD) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed October 22nd, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

NOVAVAX, INC. (NVAX) REPORT OVERVIEW

Novavax's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Novavax reported revenue of $10.77MM vs $6.73MM (up 60.03%) and analysts estimated basic earnings per share -$0.12 vs -$0.16. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Novavax reported revenue of $31.18MM vs $15.35MM (up 103.06%) and analysts estimated basic earnings per share -$0.63 vs -$1.03. Analysts expect earnings to be released on November 6th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.15. The estimated EPS forecast for the next fiscal year is -$0.47 and is expected to report on March 13th, 2019.

To read the full Novavax, Inc. (NVAX) report, download it here: http://MarketSourceResearch.com/register/?so=NVAX

-----------------------------------------

CAESARS ENTERTAINMENT CORPORATION (CZR) REPORT OVERVIEW

Caesars Entertainment's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Caesars Entertainment reported revenue of $2,119.00MM vs $1,008.00MM (up 110.22%) and analysts estimated basic earnings per share $0.04 vs -$9.62. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Caesars Entertainment reported revenue of $4,852.00MM vs $3,877.00MM (up 25.15%) and analysts estimated basic earnings per share -$1.35 vs -$20.85. Analysts expect earnings to be released on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last year was -$1.19. The estimated EPS forecast for the next fiscal year is $0.02 and is expected to report on March 6th, 2019.

To read the full Caesars Entertainment Corporation (CZR) report, download it here: http://MarketSourceResearch.com/register/?so=CZR

-----------------------------------------

SEAWORLD ENTERTAINMENT, INC. (SEAS) REPORT OVERVIEW

SeaWorld Entertainment's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, SeaWorld Entertainment reported revenue of $391.92MM vs $373.75MM (up 4.86%) and analysts estimated basic earnings per share $0.26 vs -$2.05. For the twelve months ended December 31st, 2017 vs December 31st, 2016, SeaWorld Entertainment reported revenue of $1,263.32MM vs $1,344.29MM (down 6.02%) and analysts estimated basic earnings per share -$2.36 vs -$0.15. Analysts expect earnings to be released on November 5th, 2018. The report will be for the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last year was $0.64. The estimated EPS forecast for the next fiscal year is $1.03 and is expected to report on February 26th, 2019.

To read the full SeaWorld Entertainment, Inc. (SEAS) report, download it here: http://MarketSourceResearch.com/register/?so=SEAS

-----------------------------------------

LENDINGTREE, INC. (TREE) REPORT OVERVIEW

LendingTree's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, LendingTree reported revenue of $184.10MM vs $152.77MM (up 20.51%) and basic earnings per share $3.43 vs $0.61 (up 462.30%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, LendingTree reported revenue of $617.74MM vs $384.40MM (up 60.70%) and analysts estimated basic earnings per share $1.30 vs $2.33 (down 44.21%). Analysts expect earnings to be released on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.88. The estimated EPS forecast for the next fiscal year is $5.29 and is expected to report on February 28th, 2019.

To read the full LendingTree, Inc. (TREE) report, download it here: http://MarketSourceResearch.com/register/?so=TREE

-----------------------------------------

CVS HEALTH CORPORATION (CVS) REPORT OVERVIEW

CVS Health's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, CVS Health reported revenue of $46,708.00MM vs $45,685.00MM (up 2.24%) and analysts estimated basic earnings per share -$2.52 vs $1.07. For the twelve months ended December 31st, 2017 vs December 31st, 2016, CVS Health reported revenue of $184,765.00MM vs $177,526.00MM (up 4.08%) and analysts estimated basic earnings per share $6.47 vs $4.93 (up 31.24%). Analysts expect earnings to be released on November 6th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $1.50. The estimated EPS forecast for the next fiscal year is $7.40 and is expected to report on February 14th, 2019.

To read the full CVS Health Corporation (CVS) report, download it here: http://MarketSourceResearch.com/register/?so=CVS

-----------------------------------------

THERAPEUTICSMD, INC. (TXMD) REPORT OVERVIEW

TherapeuticsMD's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, TherapeuticsMD reported revenue of $3.76MM vs $4.25MM (down 11.47%) and analysts estimated basic earnings per share -$0.15 vs -$0.10. For the twelve months ended December 31st, 2017 vs December 31st, 2016, TherapeuticsMD reported revenue of $16.78MM vs $19.36MM (down 13.32%) and analysts estimated basic earnings per share -$0.37 vs -$0.46. Analysts expect earnings to be released on November 5th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.07. The estimated EPS forecast for the next fiscal year is -$0.32 and is expected to report on February 19th, 2019.

To read the full TherapeuticsMD, Inc. (TXMD) report, download it here: http://MarketSourceResearch.com/register/?so=TXMD

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com

© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.